| 1 |
Chawla NS, Sayegh N, Prajapati S, Chan E, Pal SK, Chehrazi-Raffle A. An Update on the Treatment of Papillary Renal Cell Carcinoma. Cancers (Basel) 2023;15. [PMID: 36765524 DOI: 10.3390/cancers15030565] [Reference Citation Analysis]
|
| 2 |
Al Ashour BH, Azam F, Ibnshamsah F, Alrowais F, Al-garni A, Al-shamsi HO, Bukhari N. Metastatic Type II Papillary Renal Cell Carcinoma With Recurrent Complete Responses to Sunitinib: A Case Report With a Literature Review. Cureus 2022. [DOI: 10.7759/cureus.25541] [Reference Citation Analysis]
|
| 3 |
Trevisani F, Floris M, Vago R, Minnei R, Cinque A. Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge? Cells 2022;11:1658. [PMID: 35626699 DOI: 10.3390/cells11101658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Basree MM, Rudy R, Romaniello C, Smith DE, Kander E. Progressive Global Ataxia With Sensory Changes as a Paraneoplastic Syndrome in a Patient With Chromophobe Renal Cell Carcinoma. Cureus 2022. [DOI: 10.7759/cureus.24913] [Reference Citation Analysis]
|
| 5 |
Miller K, Bergmann L, Doehn C, Grünwald V, Gschwend JE, Ivanyi P, Kuczyk MA. [Interdisciplinary recommendations for the treatment of advanced renal cell carcinoma]. Aktuelle Urol 2021. [PMID: 34852368 DOI: 10.1055/a-1579-0562] [Reference Citation Analysis]
|
| 6 |
Lobo J, Ohashi R, Helmchen BM, Rupp NJ, Rüschoff JH, Moch H. The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth. Biomedicines 2021;9:1418. [PMID: 34680535 DOI: 10.3390/biomedicines9101418] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 7 |
Iacovelli R, Cannella MA, Ciccarese C, Astore S, Foschi N, Palermo G, Tortora G. 2021 ASCO genitourinary cancers symposium: a focus on renal cell carcinoma. Expert Rev Anticancer Ther 2021;21:1203-6. [PMID: 34482771 DOI: 10.1080/14737140.2021.1976147] [Reference Citation Analysis]
|
| 8 |
Bergmann L, Weber S, Hartmann A, Ahrens M. Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview. Expert Rev Anticancer Ther 2021;:1-14. [PMID: 34291700 DOI: 10.1080/14737140.2021.1959319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Marchetti A, Rosellini M, Mollica V, Rizzo A, Tassinari E, Nuvola G, Cimadamore A, Santoni M, Fiorentino M, Montironi R, Massari F. The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory? Int J Mol Sci 2021;22:6237. [PMID: 34207825 DOI: 10.3390/ijms22126237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Larroquette M, Peyraud F, Domblides C, Lefort F, Bernhard JC, Ravaud A, Gross-Goupil M. Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives. Cancer Treat Rev 2021;97:102207. [PMID: 33906023 DOI: 10.1016/j.ctrv.2021.102207] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 11 |
Greene C, Barlesi B, Tarroza-David S, Friedlander T. Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report. Oncol Ther 2021;9:247-53. [PMID: 33826111 DOI: 10.1007/s40487-021-00147-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Peyraud F, Larroquette M, Ravaud A, Gross-Goupil M. New Insights into Adjuvant Therapy in Renal Cell Carcinoma: Is the Chapter of VEGF Inhibitors Definitely Closed? Eur Urol 2021;80:269-74. [PMID: 33810923 DOI: 10.1016/j.eururo.2021.03.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Ishihara H, Tachibana H, Takagi T, Yoshida K, Kondo T, Tanabe K. Effect of improved systemic therapy on patient survival in metastatic non-clear-cell renal cell carcinoma. Int J Urol 2021;28:605-7. [PMID: 33615577 DOI: 10.1111/iju.14523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 14 |
Incorvaia L, Procopio G, Porta C. Renal Cancer. Practical Medical Oncology Textbook 2021. [DOI: 10.1007/978-3-030-56051-5_45] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 15 |
Miller K, Bergmann L, Doehn C, Grünwald V, Gschwend JE, Ivanyi P, Keilholz U, Kuczyk MA. [Interdisciplinary recommendations for the treatment of advanced metastatic renal cell carcinoma]. Aktuelle Urol 2020;51:572-81. [PMID: 33027832 DOI: 10.1055/a-1252-1780] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 16 |
Staehler M, Goebell PJ, Müller L, Emde TO, Wetzel N, Kruggel L, Jänicke M, Marschner N; RCC-Registry Group (Tumour Registry of Advanced Renal Cell Carcinoma). Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry. Int J Cancer 2020;146:1307-15. [PMID: 31498894 DOI: 10.1002/ijc.32671] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 17 |
Oake JD, Patel P, Lavallée LT, Lattouf JB, Saarela O, Klotz L, Moore RB, Kapoor A, Finelli A, Rendon RA, Kawakami J, So AI, Drachenberg DE. Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large, Canadian, multi-institutional database. Can Urol Assoc J 2020;14:24-30. [PMID: 31348746 DOI: 10.5489/cuaj.5941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 18 |
Marchioni M, Bandini M, Preisser F, Tian Z, Kapoor A, Cindolo L, Primiceri G, Berardinelli F, Briganti A, Shariat SF, Schips L, Karakiewicz PI. Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study. European Urology Focus 2019;5:488-96. [DOI: 10.1016/j.euf.2017.11.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 19 |
Strizova Z, Taborska P, Stakheev D, Partlová S, Havlova K, Vesely S, Bartunkova J, Smrz D. NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma. Urol Oncol 2019;37:503-9. [PMID: 31030972 DOI: 10.1016/j.urolonc.2019.03.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 20 |
Martín A, Puente J, Pinto A, Gajate P, Gordoa TA, Grande E, Herrero A, Maximiano C, Garrido M, Gallegos I, Villalobos ML, García-donas J, Caviedes E, García I, Espinosa J, Aguado C, Arranz JA, García L, Rodriguez JF, Casinello J, Rodriguez L. Real-World Outcome of 173 Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC) Cases: The Experience of the Center Group for Genitourinary Tumors. KCA 2019;3:41-50. [DOI: 10.3233/kca-180045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 21 |
Schoon JJ, Wood SL, Brown JE. TKIs in Renal Cell Carcinoma. Oncogenomics 2019. [DOI: 10.1016/b978-0-12-811785-9.00039-9] [Reference Citation Analysis]
|
| 22 |
Sirohi D, Smith SC, Agarwal N, Maughan BL. Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities. Res Rep Urol 2018;10:205-17. [PMID: 30510921 DOI: 10.2147/RRU.S154932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 23 |
Saleeb RM, Farag M, Lichner Z, Brimo F, Bartlett J, Bjarnason G, Finelli A, Rontondo F, Downes MR, Yousef GM. Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy. Mol Oncol 2018;12:1673-88. [PMID: 29896907 DOI: 10.1002/1878-0261.12346] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
